The global Dermatology Excimer Laser market size is expected to be worth around US$ 2.03 billion by 2030, according to a new report by Vision Research Reports.
The global Dermatology Excimer Laser market size was valued at US$ 401.5 million in 2020 and is anticipated to grow at a CAGR of 11.0% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38951
Table of Contents
Dermatology Excimer Laser Market Growth Factors
Dermatology excimer lasers are a novel form of targeted phototherapy that delivers a specific wavelength (308 nm) of monochromatic UVB radiation using an excimer laser or an excimer lamp. According to NCBI, excimer lasers have been proven effective in treating skin conditions like psoriasis, vitiligo, atopic dermatitis, alopecia area ta, allergic rhinitis, folliculitis, etc.
Factors like the rising prevalence of skin conditions, such as eczema, the non-invasive nature of the procedures, and the advent of technologically advanced treatment systems, offering lower complication risks, are expected to propel market growth. Skin conditions that are generally considered difficult to treat, such as hypopigmented striae and hypopigmented scars, can also be effectively treated using excimers. Technological advancement and availability of an extensive range of devices in the market that offers high patient satisfaction and visible results are expected to boost the market growth.
Dermatology Excimer Laser Market Report Coverage
Report Scope | Details |
Market Size | US$ 2.03 billion by 2030 |
Growth Rate | CAGR of 11.0% From 2021 to 2030 |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Product, Applicaion |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Ra Medical Systems; Shenzhen GSD Tech Co., Ltd.; Alma Lasers (Shanghai Fosun Pharmaceutical Group Co., Ltd.); Strata Skin Sciences, Inc.; The Daavlin Company |
By Product Analysis
The trolley-mounted excimer lasers segment held the largest revenue share of 43.3% in 2020. Based on type, the market has been segmented into tabletop excimer lasers, hand-held excimer lasers, and trolley mounted excimer lasers.
The segment is expected to maintain the leading position during the forecast period. This is because trolley-mounted lasers are portable, can be transported easily, and can be placed in any corner of a dermatology clinic.
The hand-held device segment is also expected to hold a significant market share during the forecast period as these devices provide the benefits of a lighter weight system that offers flexibility and lower investment, operation, & maintenance costs.
By Application Analysis
The psoriasis application segment held the highest market share of 22.1% in 2020 and is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the fact that the prevalence of psoriasis is on the rise.
Based on application the market has been segmented into psoriasis, vitiligo, atopic dermatitis, allergic rhinitis, alopecia areata, and others. The Atopic Dermatitis (AD) segment also held a significant market share in 2020.
Atopic dermatitis, a common chronic or recurrent inflammatory skin disease, affects 15-20% of children and 1-2% of adults globally. In the U.S., around 7.3% of adults have AD and 40% of them have moderate to severe symptoms.
By Regional Analysis
North America dominated the global market with a share of over 38% in 2020 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the rising prevalence of skin conditions, well-established medical infrastructure & reimbursement policies, presence of key market players.
The APAC regional market is expected to witness the fastest CAGR of 12.4% over the forecast period. Asian countries, such as China, Japan, and India, are emerging economies with well-developed healthcare infrastructure and facilities and are now more focused on leading on the basis of R&D activities.
Read also @ Growth of Global Veterinary Endoscopes Market Report Till 2030
Major Key Players Covered in The Dermatology Excimer Laser Market Report include
- Ra Medical Systems
- Shenzhen GSD Tech Co., Ltd.
- Alma Lasers (Shanghai FosunPharmaceutical Group Co., Ltd.)
- Strata Skin Sciences, Inc.
- The Daavlin Company
Dermatology Excimer Laser Market Segmentation
- By Product
- Table top Excimer Lasers
- Hand-held Excimer Lasers
- Trolley Mounted Excimer Lasers
- By Application
- Psoriasis
- Vitiligo
- Atopic Dermatitis
- Allergic Rhinitis
- Alopecia Areata
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Asia Pacific
- India
- Japan
- China
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Dermatology Excimer Laser Market, By Product
7.1. Dermatology Excimer Laser Market, by Product, 2021-2030
7.1.1. Table top Excimer Lasers
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Hand-held Excimer Lasers
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Trolley Mounted Excimer Lasers
7.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Dermatology Excimer Laser Market, By Application
8.1. Dermatology Excimer Laser Market, by Application, 2021-2030
8.1.1. Psoriasis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Vitiligo
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Atopic Dermatitis
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Allergic Rhinitis
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Alopecia Areata
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dermatology Excimer Laser Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 10. Company Profiles
10.1. Ra Medical Systems
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Shenzhen GSD Tech Co., Ltd.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Alma Lasers (Shanghai FosunPharmaceutical Group Co., Ltd.)
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Strata Skin Sciences, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. The Daavlin Company
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38951
Contact Us:
Vision Research Reports
Call: +1 9197 992 333